Papers to watch - The Scientist - Magazine of the Life SciencesThe ScientistScientist
Hi all i am appearing for NET exam in Life sciences subject. please send me previous years question papers (Part I & II) at sabucmd@yahoo.com i will be verymuch thankful
Call for papers Life Sciences Supports open access 12.2 CiteScore 5.2 Impact Factor Order journal 31 October 2024 AI in Drug Discovery and Therapy Development In recent years, artificial intelligence has shown promising applications in unveiling the molecular, cellular and functional basis of disease ...
Research papers, journal articles and scientific articles from journals in this sector: Here you will find abstracts and references of the latest publications by cellular-and-molecular-life-sciences-cmls.
Huapont Life Sciences to raise Yuan900 million for azoxystrobin and mesotrione projects Date:Dec. 22, 2017 Recently Huapont Life Sciences Ltd issued a private placement for fundraising of Yuan900 million for the establishment of an annual 600-ton azoxystrobin, 900-to......
Life Sciences, Society and Policyoffers authors from science, social science and the humanities a podium to discuss, compare, and assess approaches to responsible innovation, considering controversial questions and broadening the theoretical perspective. ...
The reference lists of eligible papers and relevant reviews were also meticulously searched in order to include additional studies reporting on QoL among children and adolescents with FAs. 2.2. Eligibility Criteria Articles eligible to be included in this review were required to meet the inclusion crit...
In addition, further research is needed in LCA on the complex question of the antibiotic resistance caused by antibiotic use during animal growth stages, since antibiotic use is already restricted for milking cows. 4. Conclusions This study provides a systematic, national-scale perspective on the ...
Established in year 2006 in Malaysia, Biovista is a privately-owned generic agrochemical company. Its registered and marketing office is located in southern Kua
With the life sciences industry experiencing a surge of scientific and technology advances, a sizeable gap between the innovations and the technologies exist, creating a disconnect that harms the translation of solutions into useful therapies. This whitepaper addresses how the FDA plans to close that...